Anna Berkenblit

CIK 1691868 · SVP & CHIEF MEDICAL OFFICER · last filed 2026-05-14

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

28

Lifetime Open-Market Net

-$522.7K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SRZNW Director $0.02 $0 5 2026-05-14
ImmunoGen, Inc. (IMGN) Delisted SVP & CHIEF MEDICAL OFFICER 113,935 $31.23 $3.56M -$522.7K 23 2023-07-05

Recent Filings · Page 3 of 3

28 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-02-04 ImmunoGen, Inc. (IMGN) Delisted Grant (A) $0 EDGAR
2019-01-04 ImmunoGen, Inc. (IMGN) Delisted Grant (A) +2,455 $10.0K EDGAR
2018-10-17 ImmunoGen, Inc. (IMGN) Delisted Sell (S) −5,851 -$46.8K EDGAR
2018-09-11 ImmunoGen, Inc. (IMGN) Delisted Sell (S) −5,851 -$55.4K EDGAR
2018-02-23 ImmunoGen, Inc. (IMGN) Delisted Sell (S) −17,329 -$188.5K EDGAR
2018-02-20 ImmunoGen, Inc. (IMGN) Delisted Grant (A) $0 EDGAR
2017-09-18 ImmunoGen, Inc. (IMGN) Delisted Sell (S) −1,500 -$10.5K EDGAR
2017-02-23 ImmunoGen, Inc. (IMGN) Delisted Grant (A) +157,300 $388.5K EDGAR
Showing 2128 of 28
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.